The use of tadalafil in the treatment of lower urinary tract symptoms among men suffering from benign prostatic hyperplasia, on the example of the population of the Greater Poland province
Abstract
Abstract The purpose of this study was to evaluate the efficacy of tadalafil 5 mg in patients over 65 years old previously treated for benign prostatic hyperplasia (BPH) with tamsulosin 0.4 mg in the Greater Poland region. A total of 126 patients who had not previously used tadalafil or other 5-phosphodiesterase inhibitors were initially analyzed. They were assessed using the International Prostatic Symptom Scale (IPSS) and the International Erectile Index Scale (IIEF-5), with mean scores of 25 points and 16 points, respectively. After excluding patients with contraindications, 81 men met the medical criteria for tadalafil inclusion. After three months of therapy, patients were reassessed on the IPSS and IIEF-5 scales, with mean scores of 21 points and 19 points, respectively. The results of the study suggest that tadalafil 5 mg is effective in improving both lower urinary tract symptoms associated with BPH and erectile function in older patients.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.